HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.

Saved in:
Bibliographic Details
Title: HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Authors: Cooper S; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom. Electronic address: siancooper1@nhs.net., Westley RL; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Biscombe K; The Institute of Cancer Research, Sutton, United Kingdom., Dunlop A; University Medical Center Utrecht, Utrecht, the Netherlands., Mitchell A; University Medical Center Utrecht, Utrecht, the Netherlands., Oelfke U; University Medical Center Utrecht, Utrecht, the Netherlands., Nill S; University Medical Center Utrecht, Utrecht, the Netherlands., Manning G; The Institute of Cancer Research, Sutton, United Kingdom., Burnett S; The Institute of Cancer Research, Sutton, United Kingdom., Murray J; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Wilkins A; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Tunariu N; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Price D; Patient and Public Involvement Representative, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Adkins A; Patient and Public Involvement Representative, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Pathmanathan A; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Bucinskaite G; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Hafeez S; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Parker C; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Ratnakumaran R; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Verkooijen H; Joint Department of Physics, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, United Kingdom., Alexander S; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom., Herbert T; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom., Hall E; The Institute of Cancer Research, Sutton, United Kingdom., Tree AC; The Royal Marsden Hospital NHS Foundation Trust, Sutton, United Kingdom; The Institute of Cancer Research, Sutton, United Kingdom.
Source: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2025 Nov 01; Vol. 123 (3), pp. 773-782. Date of Electronic Publication: 2025 May 20.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II
Journal Info: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-355X
DOI:10.1016/j.ijrobp.2025.05.008